Latest biotechnology News | Page 4

Neuren Pharmaceuticals completes Phelan-McDermid syndrome Phase 2 trial 
University of Queensland to establish world-leading mRNA laboratory
Telix says first patient dosed in ProstACT study of prostate cancer candidate
New report demonstrates benefit of long-term policy commitment
ARC Discovery project funding for geometry of the genome and the engineering of solid-state sodium batteries announced
HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO
New order for brewer’s yeast
Clarity says recruitment target achieved for Phase II SAR-Bombesin prostate cancer trial
Immutep announces the completion of key stage of AIPAC-003 trial in metastatic breast cancer
Cornell honored for work with international scholars
Scientists one step closer to re-writing world’s first synthetic yeast genome, unravelling the fundamental building blocks of life
November is Pancreatic Cancer Awareness Month
Appointment of Biological Sciences and Biotechnology specialist
Alum offers advice for trans allyship
UNSW tops ARC grants for Infrastructure, Equipment and Facilities
Imugene says next cohort reached in intravenous arms of monotherapy and combination study
New report quantifies the importance of R&D Tax Incentive on Australian economy
AusBiotech 2023 underway in Queensland
AusBiotech Board election result announced
AstraZeneca announces collaboration and investment agreement with Cellectis to accelerate cell therapy and genomic medicine ambitions
Bioprospecting the unknown: how bacterial enzymes encoded by unknown genes might help clean up pollution
New report quantifies impact of R&D Tax Incentive in Australia’s life sciences sector
It’s in our DNA: Australia’s biggest week in life sciences to advance biotech
Opthea announces leadership transition with the appointment of US-based executives
Emyria secures ethics endorsement for MDMA authorised prescriber application
AusBioInvest 2023 connects innovators with investment
Monash maintains position as a global frontrunner across university rankings
Boost for WA’s health and life sciences on eve of AusBiotech 2023
AusBioInvest 2023 marks beginning of Australia’s biggest week in biotech
Anteris reports positive results from interim analysis of its US-EFS Trial for DurAVR THV
Imugene announces phase 1 clinical trial opens with onCARlytics CD19 virus technology
Top performing ASX life science companies 26 October
HKUST President Prof. Nancy IP Welcomes Policy Address
FDA grants Certa Therapeutics’ FT011 orphan drug designation for systemic sclerosis
AdAlta reports favourable patient tolerability after third dose in AD-214 extension study
Positive efficacy result for Immutep’s ‘efti’ in combination with MSD’s pembrolizumab
AusBioInvest 2023 programme launched
Strength in diversity – computing healthy microbiome relationships
Shortage in regional nuclear medicine workforce attracts new financial support
J.P. Morgan’s chairman of investment banking announced as AusBioInvest keynote
New view of gene therapy
Prescient to announce Phase 1b cancer trial results at world’s largest haematology conference
Victoria backing Australia’s first stem cell trial for rare genetic disorder
Plasma jet tech transforms microalgae
Australian biotechnologists and scientists celebrated in Prime Minister’s Prizes for Science
With Proton Pump to More Growth
New approaches to blood and liver cancer therapies recognised with $2.5 million CSL Centenary Fellowships
Oculus BioMed partners with The Centre for Eye Research Australia in a deal to develop ‘SwitchGene’